Angucyclines and angucyclinones are
aromatic polyketides with intriguing
structures and therapeutic value. Genome mining of the rare marine
actinomycete Saccharothrix sp. D09 led to the identification
of a type II polyketide synthase biosynthetic gene cluster, sxn, which encodes several distinct subclasses of oxidoreductases,
implying that this strain has the potential to produce novel polycyclic
aromatic polyketides with unusual redox modifications. The “one
strain-many compounds” (OSMAC) strategy and comparative metabolite
analysis facilitated the discovery of 20 angucycline derivatives from
the D09 strain, including six new highly oxygenated saccharothrixins
D–I (1–6), four new glycosylated
saccharothrixins J–M (7–10), and 10 known analogues (11–20). Their structures were elucidated based on detailed HRESIMS, NMR
spectroscopic, and X-ray crystallographic analysis. With the help
of gene disruption and heterologous expression, we proposed their
plausible biosynthetic pathways. In addition, compounds 3, 4, and 8 showed antibacterial activity
against Helicobacter pylori with MIC values ranging
from 16 to 32 μg/mL. Compound 3 also revealed anti-inflammatory
activity by inhibiting the production of NO with an IC50 value of 28 μM.